Spectrum Pharmaceuticals stock carries a delisted status
Published on 09/29/2026 at 21:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Spectrum Pharmaceuticals stock carries a delisted status in the latest available market profile, which lists a USD 211.4 million market capitalization on September 25, 2026. The company remains associated with biotechnology and oncology, while its verified security record uses the identifier US84763A1088 rather than the identifier supplied for this request, according to Eulerpool.
Delisted status changes the stock story
Eulerpool marks Spectrum Pharmaceuticals as delisted and identifies SPPI as the ticker. The same profile names Nasdaq as the historical primary listing and places the company in the Health sector and Biotechnology industry.
The profile also describes Spectrum Pharmaceuticals as a US biotechnology company focused on developing and commercializing therapies for cancer and other serious diseases. Its historical business description includes oncology and hematology products, providing the clearest operating context for the security.
Historical figures show deep losses
Eulerpool reports historical 2022 revenue of USD 10.11 million, EBIT of minus USD 72.70 million and net income of minus USD 78.10 million. The net loss exceeded the EBIT loss by USD 5.40 million, underscoring the gap between operating performance and the final result.
The same source lists 183.24 million shares for 2025 and a historical 2022 earnings per share figure of minus USD 0.43. These figures describe the company's reported history rather than a live exchange quotation.
Reference details for SPPI
Spectrum Pharmaceuticals was founded in 1987 and had an initial public offering on September 26, 1996, according to the linked company profile. Its stated business model covered drug development, commercialization and collaborations in oncology and hematology.
Spectrum Pharmaceuticals reference data
- Company: Spectrum Pharmaceuticals, Inc.
- Ticker: SPPI
- Primary exchange: Nasdaq, historical listing
- Market capitalization: USD 211.4 million (as of September 25, 2026)
- Sector / Industry: Health / Biotechnology
- Listing status: Delisted
